An M. tuberculosis–specific IFN-γ enzyme-linked immunospot (ELISPOT) assay is helpful to differentiate between individuals with LTBI and truly healthy individuals but cannot distinguish between latent infection and active TB [10], [17], [18]. This evidence concerns the gene IFNG and disease arising from reactivation of latent virus.